期刊文献+

口服避孕药预处理在体外受精-胚胎移植中的研究 被引量:4

The study of the effects of oral contraceptive pill pretreatment in ovarian stimulation for in vitro fertilization embryo transfer cyclesw.
下载PDF
导出
摘要 目的研究促排卵周期前应用口服避孕药(OCP)在体外受精-胚胎移植(IVF)中的意义。方法回顾性分析98例行IVF的患者,按排卵周期前是否使用过OCP药物分为OCP治疗组52例和对照组46例,对入选患者的病历资料进行统计分析,评估口服避孕药对患者促排卵的效果以及对助孕结果的影响。结果OCP预处理明显减少卵巢功能性囊肿形成(P=0.0016),OCP处理组比对照组Gn天数平均增加1.29d(P=0.007),剂量平均增加492 IU(P=0.003),成熟卵率更高,但两组获卵数、受精率、流产率、临床妊娠率等差异均无统计学意义。结论OCP预处理能较好地控制促排卵的时间,有效减少医务人员周末上班时间,能使卵巢反应性得到部分改善,卵泡发育同步性更高,但Gn天数与Gn剂量较对照组增加。 Objective To assess the effects of oral contraceptive pill(OCP)pretreatment in ovarian stimulation for in vitro fertilization(IVF) using gonadotropin releasing hormone( GnRH ) agonists. Methods Ninety-eight patients were randomized divided into group OCPs, who received OCPs pretreatment before IVF cycle ( n = 52 ), and group B, who did not ( n = 46 ). A retrospective analysis of the anamnestic data of the patients was carried out for the assessment of the ovulation promoting effect of OCP and their influence on the IVF- ET operation. Results The formation of ovarian cyst was significant decreased in OCPs group( P = 0. 0016 ). Compared with the control group,a mean of 1.29 days were increased in OCPs pretreatment group(8.52 versus 9.81 days, P = 0.007) ,and an average of 492IU gonadotropin were more consumed in OCPs group ( 2502 IU versus 2010 IU, P = 0.003). The ratio of ovium were increased in OCPs pretreatment group(93.3% versus 87.2%, P = 0.001 ), but no significant differences were observed regarding the number of cumulusoocyte complexes (COCs), fertility rates, abortion rates, clinical pregnancy rates and the fertilization ratexs. Conclusion Oral contraceptive pill(OCP) pretreatment could help the doctor to control the time of ovarian stimulation, effectively reduce the work time of medical staff on weekends. It may improve the respensivity of ovary moderately and increase the synchronism of follicular development, though the duration of gonadotropin stimulation and the gonadotropin consumption were signitlcanfly increased in OCP pretreatment groups.
出处 《四川医学》 CAS 2008年第11期1529-1531,共3页 Sichuan Medical Journal
关键词 避孕药 口服 体外受精-胚胎移植 超排卵 oral contraceptive pill in vitro fertilization embryo transfer(IVF-ET) superovulation
  • 相关文献

参考文献1

二级参考文献7

  • 1KOVACS P,BARG P E,WITT B R.Hypothalamic-pituitary suppression with oral contraceptive pills does not improve outcome in poor responder patients undergoing in vitro fertilization-embryo transfer cycles[J].J Assist Reprod Genet,2001,18 (7):391-394.
  • 2TARLATZISB C,ZEPIRIDISL A,GRIMBIZISG A.Clinical management of low ovarian response to stimulation for IVF:a systematic review[J].Hum Reprod Update,2003,9 (1):61-76.
  • 3UBALDIF M,RIENZIL A,FERREROS,et al.Management of poor responders in IVF[J].Reprod Biomed Online,2005,10 (2):235 -246.
  • 4MARTIN J S,NIKER J A,TUMMOV I S,et al.Future in vitro fertilization pregnancy potential of women with variably elevated day 3 follicle-stimulating hormone levels[J].Fertil Steril,1996,65 (6):1238-1240.
  • 5BARMATL I,CHANTILISS J,HURSTB S,et al.A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH)antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization[J].Fertil Steril,2005,83 (2):321-330.
  • 6KOVA S,BARG P E,WITT B R,et al.Hypothalamic-Pituitary Suppression with Oral Contraceptive Pills Does Not Improve Outcome in Poor Responder Patients Undergoing In Vitro Fertilization-Embryo Transfer Cycles[J].J Assi Repro Genetics,2001,7:391-394.
  • 7AL-MIZYENE A,SABATINIL B,LOWERA M,et al.Does pretreatment with progestogen or oral contraceptive pills in low responders followed by the GnRHa flare protocol improve the outcome of IVF-ET?[J].J Assist Reprod Genet,2000,17 (3):140-146.

共引文献17

同被引文献44

  • 1李舟,朱桂金,靳镭,章汉旺.口服避孕药对体外受精-胚胎移植术中卵巢反应不良患者的意义[J].医药导报,2007,26(2):168-170. 被引量:18
  • 2唐慧珍,高士友,阳翎,邓朝辉,陈辉莲,李燕,汤倩倩.口服避孕药联合促性腺激素释放激素激动剂在体外受精—胚胎移植中的临床观察[J].实用预防医学,2007,14(1):44-45. 被引量:5
  • 3Gonen Y, Jacobson W, Casper RF. Gonadotropin suppression with oral contraceptives before in vitro fertilization. Fertil Steril, 1990, 53:282-287.
  • 4Cedrin-Durnerin I, Bstandig B, Parneix I, et al. Effects of oral contraceptive, synthetic progestogen or natural estrogen pretreatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol. Hum Reprod , 2007, 22:109- 116.
  • 5Kovacs P, Barg PE, Witt BR. Hypothalamie-pituitary suppression with oral contraceptive pills does not improve outcome in poor responder patients undergoing in vitro fertilization-embryo transfer cycles. J Assist Reprod Genet, 2001, 18:391-394.
  • 6Efstratios M, Kolibianakis EM, Papanikolaou EG, et al. Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum Reprod , 2006, 21 : 352-357.
  • 7Rombauts L, Healy D, Norman RJ. A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients. Hum Reprod , 2006, 21:95-103.
  • 8Drakakis P, Loutradis D, Kallianidis K, et al. Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET. Eur J Obstet Gynecol Reprod Biol, 2005, 121:77-80.
  • 9Pinkas H, Sapir O, Avrech OM, et al. The effect of oral contraceptive pill for cycle scheduling prior to GnRH-antagonist protocol on IVF cycle parameters and pregnancy outcome. J Assist Reprod Genet, 2008 ,25:29-33.
  • 10Boddy JL, Fox SB, Han C. The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer. Clin Cancer Res, 2005, 11:7658-7663.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部